MSLE
Satellos Bioscience Inc. Common Stock
There isn't enough reported data to score MSLE yet.
MSLE Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
MSLE's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
MSLE PE Valuation
MSLE has no meaningful PE right now: it lost money over the past year.
MSLE Forward outlook
There aren't enough analyst estimates for MSLE to show an outlook.
MSLE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.92 | -$0.11 |
| Q1 2026 | -$1.73 | +$0.17 |
| Q4 2025 | -$1.64 | +$0.33 |
| Q3 2025 | -$1.48 | +$0.66 |
| Q2 2025 | -$1.81 | -$0.09 |
| Q1 2025 | -$1.90 | -$0.19 |
| Q4 2024 | -$1.97 | -$0.44 |
| Q3 2024 | -$2.14 | -$0.08 |
MSLE is still losing money, but far less than before: $1.92 per share over the past year, against $5.37 at its worst in mid-2022.
MSLE Quarterly Revenue
MSLE's revenue is shrinking: $0 last quarter.
MSLE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$7.8M | -$3M |
| Q1 2026 | -$9.5M | -$2.1M |
| Q4 2025 | -$7.3M | -$4M |
| Q3 2025 | -$4.1M | -$1M |
| Q2 2025 | -$4.8M | -$867.4K |
| Q1 2025 | -$7.4M | -$2.1M |
| Q4 2024 | -$3.3M | +$521.6K |
| Q3 2024 | -$3.1M | -$338.5K |
MSLE has burned cash in almost every quarter: −$29M over the past year, against −$19M the year before.
MSLE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +2.4M shares |
| 1 year | +46% | +6.6M shares |
| 3 years | +220% | +14.3M shares |
| 5 years | +1283% | +19.3M shares |
| Available history | +3734% | +20.3M shares |
MSLE has 21M diluted shares, up 46% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
MSLE hasn't bought back shares in the past year.
MSLE Net Leverage
MSLE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MSLE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 16.5 | Oversold |
MSLE's weekly RSI is 40 (neutral) and its Stochastic is 17 (oversold).
MSLE PE vs Healthcare Sector
MSLE has no meaningful PE right now: it lost money over the past year.
MSLE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.29 | 6.3% below |
| 20 week MA | $8.53 | 20% below |
MSLE is in a downtrend: it's below all two of its weekly moving averages, and 20% below its 20-week average.
MSLE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $11.6 | $6.83 | -41% |
It's down 41% so far in 2026.